Experts are concerned that the country’s world-renowned health institutions are responsible for overseeing the approval and delivery processes, which have increasingly compromised political pressure, which could end up costing lives.
The Food and Drug Administration (FDA) and the Centers for Disease Control and Prevention (CDC) are at the center of the storm.
Two agencies historically considered partisan have earned widespread respect for the international scientific community.
But his experts are now viewed with intense skepticism by Trump’s top lieutenants, who see him as resistant to the president’s agenda of reopening the economy.
Senior scientists at the CDC, who will brief the press on past health crises, were the first to sound the alarm on coronoviruses but have been sidelined since March.
The official CDC Guidelines, long considered a global benchmark, were mysteriously revised over the summer – first by strongly tilting recommendations towards in-person reopening schools, and later by this advice Giving that people exposed to Kovid-19 patients do not require testing if they are asymptomatic.
The second step was seen as particularly arrogant because no scientific reasoning was introduced – but it did tie in with Trump’s desire to satisfy lesser desires.
Last week, Politico reported that Michael Capto, the head of the federal health department, had for months sought to revise scientific reports on the virus published in the CDC’s “Morbity and Mortality Weekly Report” – for example at the infectious level. children.
A member of MMWR’s editorial board, William Scheffner, told AFP, “It is unprecedented for the political leadership of the United States to infiltrate the scientific functioning of those agencies.”
According to the New York Times, Caputo doubled in a Facebook post on Sunday accusing Career government scientists of “treason”.
He also claimed that the CDC harassed a “resistance unit” determined to undermine Trump, and that the leftist hit squads were preparing for an armed rebellion.
– ‘Culture of fear’ –
Eric Topol, director of the Scripps Research Translational Institute, says the FDA’s credibility as the world’s most influential drug regulator has been tarnished in a way that may affect the most important decision of the pandemic:
He cites two major incidents.
In March, the body authorized the emergency use of hydroxychloroquine, an old anti-malarial drug touted by Trump, despite the lack of evidence for its effectiveness against codrid-19.
The authority was revoked in June over security concerns.
In August, after Trump prepared to go before the Republican National Convention, the FDA issued emergency approval for blood plasma transfusion from recovered Kovid-19 patients.
But FDA Commissioner Stephen Hahn misrepresented an important statistic suggesting that plasma had a life-saving effect. Han later apologized and retracted his statement.
Hahn has dismissed claims that his agency has faced pressure from the White House and insisted on the inclusion of independent experts in the review process.
“We will not jeopardize public confidence in our science-based, independent review of these or any vaccines,” he said in a tweet last week.
According to Trump’s suggestion, there is unlikely to be enough data for phase-level trials by the end of October, when a vaccine may be ready.
It is also unlikely that a company will stake its reputation on a drug that is not ready.
But experts remain skeptical, singling out daily statements by the CEO of Pfizer near a vaccine that is cause for concern.
“I think there’s going to be an unfortunate pressure campaign to approve them,” said Michael Hina, a Harvard epidemiologist.
The two agencies “have become subservient to the Trump White House people,” Topol said, citing a “culture of fear” – losing or having someone’s job at the end of a hostile presidential tweet after mistreating his supporters Of.
CDC director Robert Redfield, who continues TopCol, “has allowed his agency to become basically a non-entity”, concluding that: “If these people were in principle, they would have resigned.”
According to the New York Times, career scientists at the CDC are considering it.